Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax
Ibrutinib is an irreversible inhibitor of Bruton’s tyrosine kinase (BTK), a cytoplasmic tyrosine kinase of the Tec family, which plays an important role in the B-cell receptor signaling pathway [1]. Ibrutinib is used for the treatment of chronic lymphocytic leukemia, mantle cell lymphoma, Waldenströ...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2022-03-01
|
| Series: | Polish Journal of Thoracic and Cardiovascular Surgery |
| Online Access: | https://www.termedia.pl/Ibrutinib-associated-alveolar-hemorrhage-r-nand-spontaneous-hemothorax,40,46610,1,1.html |